Literature DB >> 20357977

Simultaneous protein expression and modification: an efficient approach for production of unphosphorylated and biotinylated receptor tyrosine kinases by triple infection in the baculovirus expression system.

Dirk Erdmann1, Catherine Zimmermann, Patrizia Fontana, Jean-Christophe Hau, Alain De Pover, Patrick Chène.   

Abstract

Protein kinases can adopt multiple protein conformations depending on their activation status. Recently, in drug discovery, a paradigm shift has been initiated, moving from inhibition of fully activated, phosphorylated kinases to targeting the inactive, unphosphorylated forms. For identification and characterization of putative inhibitors, also interacting with the latent kinase conformation outside of the kinase domain, highly purified and homogeneous protein preparations of unphosphorylated kinases are essential. The kinetic parameters of nonphosphorylated kinases cannot be assessed easily by standard kinase enzyme assays as a result of their intrinsic autophosphorylation activity. Kinetic binding rate constants of inhibitor-protein interactions can be measured by biophysical means upon protein immobilization on chips. Protein immobilization can be achieved under mild conditions by binding biotinylated proteins to streptavidin-coated chips, exploiting the strong and highly specific streptavidin-biotin interaction. In the work reported here, the cytoplasmic domains of insulin receptor and insulin-like growth factor-1 receptor fused to a biotin ligase recognition sequence were coexpressed individually with the phosphatase YopH and the biotin-protein ligase BirA upon triple infection in insect cells. Tandem affinity purification yielded pure cytoplasmic kinase domains as judged by gel electrophoresis and HPLC. Liquid chromatography-mass spectrometry analysis showed the absence of any protein phosphorylation. Coexpression of BirA led to quantitative and site-specific biotinylation of the kinases, which had no influence on the catalytic activity of the kinases, as demonstrated by the identical phosphorylation pattern upon autoactivation and by enzymatic assay. This coexpression approach should be applicable to other protein kinases as well and should greatly facilitate the production of protein kinases in their phosphorylated and unphosphorylated state suitable for enzymatic and biophysical studies.

Entities:  

Keywords:  biotin; phosphatase; phosphorylation

Mesh:

Substances:

Year:  2010        PMID: 20357977      PMCID: PMC2841998     

Source DB:  PubMed          Journal:  J Biomol Tech        ISSN: 1524-0215


  33 in total

1.  Loss of ELISA specificity due to biotinylation of monoclonal antibodies.

Authors:  G Høyer-Hansen; M J Hamers; A N Pedersen; H J Nielsen; N Brünner; K Danø; R W Stephens
Journal:  J Immunol Methods       Date:  2000-02-21       Impact factor: 2.303

2.  Structure and autoregulation of the insulin-like growth factor 1 receptor kinase.

Authors:  S Favelyukis; J H Till; S R Hubbard; W T Miller
Journal:  Nat Struct Biol       Date:  2001-12

Review 3.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

Review 4.  Protein kinases--the major drug targets of the twenty-first century?

Authors:  Philip Cohen
Journal:  Nat Rev Drug Discov       Date:  2002-04       Impact factor: 84.694

5.  Expression, purification, and physicochemical characterization of a recombinant Yersinia protein tyrosine phosphatase.

Authors:  Z Y Zhang; J C Clemens; H L Schubert; J A Stuckey; M W Fischer; D M Hume; M A Saper; J E Dixon
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

6.  In vivo biotinylation of the major histocompatibility complex (MHC) class II/peptide complex by coexpression of BirA enzyme for the generation of MHC class II/tetramers.

Authors:  Junbao Yang; Andrés Jaramillo; Ruili Shi; William W Kwok; T Mohanakumar
Journal:  Hum Immunol       Date:  2004-07       Impact factor: 2.850

7.  Biotination of proteins in vivo. A post-translational modification to label, purify, and study proteins.

Authors:  J E Cronan
Journal:  J Biol Chem       Date:  1990-06-25       Impact factor: 5.157

Review 8.  Issues and progress with protein kinase inhibitors for cancer treatment.

Authors:  Janet Dancey; Edward A Sausville
Journal:  Nat Rev Drug Discov       Date:  2003-04       Impact factor: 84.694

9.  Production of a biotinylated single-chain antibody fragment in the cytoplasm of Escherichia coli.

Authors:  Ville Santala; Urpo Lamminmäki
Journal:  J Immunol Methods       Date:  2004-01       Impact factor: 2.303

10.  In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase.

Authors:  Carlos García-Echeverría; Mark A Pearson; Andreas Marti; Thomas Meyer; Juergen Mestan; Johann Zimmermann; Jiaping Gao; Josef Brueggen; Hans-Georg Capraro; Robert Cozens; Dean B Evans; Doriano Fabbro; Pascal Furet; Diana Graus Porta; Janis Liebetanz; Georg Martiny-Baron; Stephan Ruetz; Francesco Hofmann
Journal:  Cancer Cell       Date:  2004-03       Impact factor: 31.743

View more
  1 in total

1.  Carboxyl-group footprinting maps the dimerization interface and phosphorylation-induced conformational changes of a membrane-associated tyrosine kinase.

Authors:  Hao Zhang; Wei Shen; Don Rempel; John Monsey; Ilan Vidavsky; Michael L Gross; Ron Bose
Journal:  Mol Cell Proteomics       Date:  2011-03-21       Impact factor: 5.911

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.